Skip to main content
. Author manuscript; available in PMC: 2024 Feb 21.
Published in final edited form as: J Mood Anxiety Disord. 2023 Jun 9;1:100004. doi: 10.1016/j.xjmad.2023.100004

Table 2.

Linear Effects of Timepoint and Interactions with Treatment-Arm, from Pre-Treatment through Weekly and Post-Treatment Timepoints.

Coef. d 95% CI of Coef.

Lower Upper
GAD-7
 Timepoint −5.37 −0.54 −6.74 −4.00
 Treatment-Arm 2.34 ** 0.70 0.84 3.84
 Treatment-Arm by Timepoint 1.79 0.40 −0.17 3.75
PROMIS Anxiety
 Timepoint −8.22 *** −0.65 −9.95 −6.49
 Treatment-Arm 2.48 * 0.57 0.53 4.43
 Treatment-Arm by Timepoint 4.21 *** 0.75 1.72 6.70
PROMIS Depression
 Timepoint −6.75 *** −0.53 −8.50 −5.00
 Treatment-Arm 0.32 0.05 −2.32 2.95
 Treatment-Arm by Timepoint Sheehan 4.41 *** 0.77 1.89 6.94
 Timepoint −8.75 *** −0.71 −10.45 −7.05
 Treatment-Arm 2.62 0.43 −0.09 5.32
 Treatment-Arm by Timepoint 3.34 ** 0.59 0.83 5.85
BADS
 Timepoint 11.53 *** 0.64 9.02 14.04
 Treatment-Arm −1.53 −0.21 −4.73 1.67
 Treatment-Arm by Timepoint −4.64 * −0.55 −8.35 −0.94

Note. Models take the form symptom ~ timepoint × treatment + age + sex + education, with participant ID and treatment group entered as random effects. BA: behavioral activation; EXP: exposure; GAD-7: Generalized Anxiety Disorder Scale – 7-item, PROMIS: Patient-Reported Outcomes Measurement Information System; SDS: Sheehan Disability Scale; BADS: Behavioral Activation for Depression Scale.

***

p < .001,

**

p < .01,

*

p < .05.